Table 2 of
Zhou, Mol Vis 2012; 18:309-316. Table 2 of
Zhou, Mol Vis 2012; 18:309-316.
Table 2. Clinical features of carriers with CHM.
Patient |
Age of test |
Symptoms and signs |
|---|---|---|
| F1-II-2 | 45 | hypopigment changes in the midperiphery area fine RPE mottling patchy areas of chorioretinal atrophy (Figure 7A) |
| F2-II-2 | 71 | NA; Fundus: diffuse punctate hypopigmentary changes (Figure 7B) |
| F2-II-3 | 67 | NA; Fundus: diffuse punctate hypopigmentary changes |
| F3-II-2 | 69 | Decreased vision Refraction:OD 0–3.50×130 20/60; OS +0.50+1.25×40 20/30; Fundus: see Figure 7C ERG: reduced rod and cone amplitude VF: constricted, central 20° VF |
| F3-IV-1 | 17 | Refraction; OD −1.25–0.75×160 20/20; −1.00–1.00×8 20/20 |